These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 10666186)

  • 1. Limited expression of R5-tropic HIV-1 in CCR5-positive type 1-polarized T cells explained by their ability to produce RANTES, MIP-1alpha, and MIP-1beta.
    Annunziato F; Galli G; Nappi F; Cosmi L; Manetti R; Maggi E; Ensoli B; Romagnani S
    Blood; 2000 Feb; 95(4):1167-74. PubMed ID: 10666186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1alpha, MIP-1beta and RANTES beta-chemokines.
    Dolei A; Biolchini A; Serra C; Curreli S; Gomes E; Dianzani F
    AIDS; 1998 Jan; 12(2):183-90. PubMed ID: 9468367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphoantigen-reactive Vgamma9Vdelta2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines.
    Poccia F; Battistini L; Cipriani B; Mancino G; Martini F; Gougeon ML; Colizzi V
    J Infect Dis; 1999 Sep; 180(3):858-61. PubMed ID: 10438380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.
    Xiang J; George SL; Wünschmann S; Chang Q; Klinzman D; Stapleton JT
    Lancet; 2004 Jun; 363(9426):2040-6. PubMed ID: 15207954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.
    Maeda Y; Foda M; Matsushita S; Harada S
    J Virol; 2000 Feb; 74(4):1787-93. PubMed ID: 10644351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
    Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E
    J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in CCR5 and CXCR4 expression and beta-chemokine production in HIV-1-infected patients treated with highly active antiretroviral therapy.
    Pierdominici M; Giovannetti A; Ensoli F; Mazzetta F; Marziali M; De Cristofaro MR; Santini-Muratori D; Leti W; Aiuti F
    J Acquir Immune Defic Syndr; 2002 Feb; 29(2):122-31. PubMed ID: 11832680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage-tropic HIV induces and exploits dendritic cell chemotaxis.
    Lin CL; Sewell AK; Gao GF; Whelan KT; Phillips RE; Austyn JM
    J Exp Med; 2000 Aug; 192(4):587-94. PubMed ID: 10952729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy.
    Giovannetti A; Ensoli F; Mazzetta F; De Cristofaro M; Pierdominici M; Muratori DS; Fiorelli V; Aiuti F
    Clin Exp Immunol; 1999 Oct; 118(1):87-94. PubMed ID: 10540164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for Gag p24-specific CD4 T cells with reduced susceptibility to R5 HIV-1 infection in a UK cohort of HIV-exposed-seronegative subjects.
    Eyeson J; King D; Boaz MJ; Sefia E; Tomkins S; Waters A; Easterbrook PJ; Vyakarnam A
    AIDS; 2003 Nov; 17(16):2299-311. PubMed ID: 14571181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR5 and CXCR4 expression correlated with X4 and R5 HIV-1 infection yet not sustained replication in Th1 and Th2 cells.
    Moonis M; Lee B; Bailer RT; Luo Q; Montaner LJ
    AIDS; 2001 Oct; 15(15):1941-9. PubMed ID: 11600821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
    Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F
    J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains.
    Alfano M; Schmidtmayerova H; Amella CA; Pushkarsky T; Bukrinsky M
    J Exp Med; 1999 Sep; 190(5):597-605. PubMed ID: 10477545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel role for tumor necrosis factor-alpha in regulating susceptibility of activated CD4+ T cells from human and nonhuman primates for distinct coreceptor using lentiviruses.
    Brice GT; Mayne AE; Villinger F; Ansari AA
    J Acquir Immune Defic Syndr; 2000 May; 24(1):10-22. PubMed ID: 10877490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is decreased HIV-1 infectivity of placental macrophages caused by high levels of beta-chemokines?
    Meléndez J; García V; Sánchez E; Delgado R; Torres G; Meléndez-Guerrero LM
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL51-9. PubMed ID: 11936874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of CCR5-tropic HIV type 1 infection by OX40 stimulation via enhanced production of β-chemokines.
    Tanaka R; Takahashi Y; Kodama A; Saito M; Ansari AA; Tanaka Y
    AIDS Res Hum Retroviruses; 2010 Oct; 26(10):1147-54. PubMed ID: 20854204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta, and RANTES is associated with a type 1 immune response.
    Schrum S; Probst P; Fleischer B; Zipfel PF
    J Immunol; 1996 Oct; 157(8):3598-604. PubMed ID: 8871660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.
    Trkola A; Paxton WA; Monard SP; Hoxie JA; Siani MA; Thompson DA; Wu L; Mackay CR; Horuk R; Moore JP
    J Virol; 1998 Jan; 72(1):396-404. PubMed ID: 9420238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.
    Aquaro S; Menten P; Struyf S; Proost P; Van Damme J; De Clercq E; Schols D
    J Virol; 2001 May; 75(9):4402-6. PubMed ID: 11287590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-MIP-1alpha and anti-RANTES antibodies: new allies of HIV-1?
    Kissler S; Süsal C; Opelz G
    Clin Immunol Immunopathol; 1997 Sep; 84(3):338-41. PubMed ID: 9281393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.